SUMMARY
We selected important ethical conflicts of interest in current cell biology and which remain still
unresolved: the use of human biological material, patents for biological material, cloning and use of stem
cells, genetic engineering, onset of human life and death, and the use of vertebrate biomodels. New data
from cell and molecular biology cannot facilitate the solution of such problems - on the contrary, they
make these solutions more difficult. A solution may be found within the socio-cultural problems.
Intensive research is necessary both to accomplish economical and medical benefit and to clarify ethical
rules. Thus, essential cell biology seems to be the important part of education for non-life sciences
students and students of biology and medicine would touch the social and ethical implications of recent
biotechnologies in each knowledge-based economy.
KEY WORDS
bioethics; quality control; cloning; toxicity; neuropharmacology; criminal and warlike misuse
REFERENCES
Adolphe M: Les methodes dites alternatives a
l'experimentation animale. Problemes
scientifiques et ethiques. Bull Acad Nat Med
179:1109-1119, 1995.
Alonso C: An ontological view of the human
embryo. A paradigm. Eur J Endocrinol 151:Suppl. 3, U17-U24, 2004.
[CrossRef]
[PubMed]
Bauer ME: Stress, glucocorticoids and ageing of
the immune system. Stress 8:69-83, 2005.
[CrossRef]
[PubMed]
Berger J: Ethical conflicts of interest in modern
biomedicine? J Appl Biomed 1:181-182, 2003.
[JAB]
Berger J, Walczysko S, Pavkova J, Gutzeit HO:
Effects of genistein on insect haemocytes.
J Appl Biomed 1:161-168, 2003.
[JAB]
Bongso A, Richards M: History and perspective of
stem cell research. Best Pract Clin Obst
Gynaecol 18:827-842, 2004.
[CrossRef]
Bradshaw RH: The ethical review process in the
UK and Australia: The Australian experience
of improved dialogue and communication.
Anim Welfare 11:141-156, 2002.
Caruso C, Lio D, Cavallone L, Franceschi C:
Aging, longevity, inflammation, and cancer.
Ann NY Acad Sci 1028:1-13, 2004.
[CrossRef]
[PubMed]
Christ M: Preclinical evaluation of gene transfer
products: safety and immunological aspects.
Toxicology 174:13-19, 2002.
[CrossRef]
Combes RD: The use of human cells in
biomedical research and testing. ATLA 32:Suppl 1A, 43-49, 2004.
Crespi RS: Ethico-legal issues in biomedicine
patenting: a patents professional viewpoint.
Sci Engin Ethics 11:117-136, 2005.
[CrossRef]
[PubMed]
Gilbert SF, Fausto-Sterling A: Educating for
social responsibility: changing the syllabus of
developmental biology. Int J Dev Biol 47:Sp. Iss., 237-244, 2003.
Greenfield SA: Biotechnology, the brain and the
future. Trends Biotechnol 23:34-41, 2005.
[CrossRef]
[PubMed]
Jenkins GL, Sugarman J: The importance of
cultural considerations in the promotion of
ethical research with human biologic material.
J Lab Clin Med 145:118-124, 2005.
[CrossRef]
[PubMed]
Kazmierczak SC: Laboratory quality control: using patient data to assess analytical
performance. Clin Chem Lab Med 41:617-627, 2003.
[CrossRef]
[PubMed]
Kinter LB, Valentin JP: Safety pharmacology
and risk assessment. Fund Clin Pharmacol
16:175-182, 2002.
[CrossRef]
[PubMed]
Kromka F: Equality for man and animal - a
common-sense criticism of this animal rights
concept. Ber Landwirt 81:150-158, 2003.
Lakshmipathy U, Verfaillie C: Stem cell plasticity.
Blood Rev 19:29-38, 2005.
[CrossRef]
[PubMed]
Lawson NS, Gilmore BF, Tholen DW:
Multiprogram characterization of laboratory
bias, precision, and total error - proposal for
improved assessment with shared external and
expanded internal (regional) quality-control
pools. Arch Pathol Lab Med 112:454-461, 1988.
[PubMed]
Lenoir N: Bioethique et XXIe siecle, le point de
vue du juriste. Presse Med 31:565-571, 2002.
[PubMed]
Levine MS, Cepeda C, Hickey MA, Fleming
SM, Chesselet MF: Genetic mouse models
of Huntington's and Parkinson's diseases: illuminating but imperfect. Trends Neurosci
27:691-697, 2004.
[CrossRef]
[PubMed]
Lim TM: Learning developmental biology has
priority in the life sciences curriculum in
Singapore. Int J Dev Biol 47:Sp. Iss., 117-121 2003.
Mackey T: An ethical assessment of anti-aging
medicine. J Anti-Aging Med 6:187-204, 2003.
[CrossRef]
[PubMed]
Nixdorf K, Bender W: Ethics of university
research, biotechnology and potential military
spin-off. Minerva 40:15-35, 2002.
[CrossRef]
[PubMed]
Porrello A, Cardelli P, Spugnini EP: J Exper
Clin Cancer Res 23:181-193, 2004.
[PubMed]
Rees DA, Alcolado JC: Animal models of
diabetes mellitus. Diabet Med 22:359-370, 2005.
[CrossRef]
[PubMed]
Roy DJ, Lambert RD: L'ethique des sciences de
la vie: a un carrefour? Medecine/Sciences 16:1192-1197, 2000.
Tesarik J, Greco E: A zygote is not an embryo: ethical and legal considerations. Reprod
Biomed Online 9:13-16, 2004.
[CrossRef]
Testa G, Harris J: Ethics and synthetic gametes.
Bioethics 19:146-166, 2005.
[CrossRef]
Weaver SA, Morris MC: Risks associated with
genetic modification: an annotated
bibliography of peer reviewed natural science
publications. J Agr Environm Ethics 18:157-189, 2005.
[CrossRef]
Znidarcic Z: Ethical problems in cytology.
Cytopathology 15:49-52, 2004.
[CrossRef]
[PubMed]
|
CITED
Berger J, Slavickova K: Morphological characterization of hemocytes in the adult linden bug, Pyrrhocoris apterus (L.) (Heteroptera). Zoological Stud
47:466-472, 2008.
|
